-
Designing with People with Stigmatized Conditions
The purpose of this study is to obtain feedback on designs of social support exchange technology for people living with ...
Free text
Phase N/A
-
A Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
This randomized phase II clinical trial studies how well nivolumab after combined modality therapy works in treating patients with high ...Free text
Phase N/A
Showing - of studies